ConductScience.org, home

Paper378671

Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Parvinen I and 1 other. Eur J Clin Pharmacol, 1979. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparison of once and twice daily administration of sotalol in the treatment of hypertension. Papers, record 378671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/378671

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of once and twice daily administration of sotalol in the treatment of hypertension.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2019-08-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parvinen II
2Paukkala EE

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
SotalolMajor topic
Adult
Aged
Blood Pressure
Clinical Trials as Topic
Double-Blind Method
Drug Administration Schedule
Female
Heart Rate
Humans
Male
Middle Aged
Time Factors

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,664,934To be taken as directed.J R Coll Gen Pract1968https://conductscience.org/library/papers/5664934PubMed
25,054,588Relation of propranolol plasma level to beta-blockade during oral therapy.Pharmacology1972https://conductscience.org/library/papers/5054588PubMed
3773,494Once-daily dosing with Atenolol in patients with mild or moderate hypertension.Br Med J1976https://conductscience.org/library/papers/773494PubMed
44,399,660Separation and spectrofluorometric assay of the -adrenergic blocker sotalol from blood and urine.J Pharm Sci1971https://conductscience.org/library/papers/4399660PubMed
51,071,677Clinical trial of the beta-adrenoreceptor-blocking agent tolamolol with the use of 24 hour blood pressure recordings.Clin Sci Mol Med Suppl1976https://conductscience.org/library/papers/1071677PubMed
6884,915Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions.Clin Pharmacol Ther1977https://conductscience.org/library/papers/884915PubMed
7971,701Observations on the efficacy and pharmacokinetics of sotalol after oral administration.Eur J Clin Pharmacol1976https://conductscience.org/library/papers/971701PubMed
84,606,232Antihypertensive effects of practolol and sotalol.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4606232PubMed
95,762,624Drug defaulting in a general practice.Br Med J1969https://conductscience.org/library/papers/5762624PubMed
10861,130Evaluation of once daily sotalol administration in man.Br J Clin Pharmacol1977https://conductscience.org/library/papers/861130PubMed
11988,964Human pharmacokinetics of sotalol.Acta Pharmacol Toxicol (Copenh)1976https://conductscience.org/library/papers/988964PubMed
124,152,167Beta-adrenergic receptor blocking drugs in hypertension.Drugs1974https://conductscience.org/library/papers/4152167PubMed
134,401,216Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.N Engl J Med1972https://conductscience.org/library/papers/4401216PubMed
1414,172,036USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.Br Med J1964https://conductscience.org/library/papers/14172036PubMed
15334,211Atenolol once-daily in hypertension.Br J Clin Pharmacol1977https://conductscience.org/library/papers/334211PubMed
16788,758The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.Br J Clin Pharmacol1976https://conductscience.org/library/papers/788758PubMed
17938,912Letter: Once-daily treatment of hypertension.Br Med J1976https://conductscience.org/library/papers/938912PubMed
181,052,165Control of hypertension with single daily doses of sotalol hydrochloride.Curr Med Res Opin1976https://conductscience.org/library/papers/1052165PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
7,439,252Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7439252PubMed
7,250,172Fixed combination of sotalol and hydrochlorothiazide in the treatment of uncomplicated hypertension.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7250172PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/378671

GET https://conductscience.org/api/papers/v1/378671/authors